Pilocarpine/Tolterodine

毛果芸香碱/托特罗定

Report date: 2022/07/04 19:38:02

Base Information

Drug NamePilocarpine/Tolterodine
Drug Alias NameTolterodine and Pilocarpine托特罗定毛果芸香碱Tolterodine/Pilocarpine托特罗定/毛果芸香碱毛果芸香碱托特罗定 +[9] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Pilocarpine HydrochlorideTolterodine Tartrate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTheravida Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSk Chemicals Co Ltd
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A